← Back to Search

Treatment group for Kidney Cancer

Phase 4

Waitlist Available

Led By Katie Murray, DO

Research Sponsored by University of Missouri-Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, assessed at 1h, 2h, 4h, 6h, 12h and 24h post operatively, then every 24 hours until discharge, and at the post operative visit which occurred within 21-days post-operatively.

Awards & highlights

Study Summary

This trial looks at whether less pain leads to less opioid use after surgery.

Eligible Conditions

Kidney Cancer
Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, assessed at 1h, 2h, 4h, 6h, 12h and 24h post operatively, then every 24 hours until discharge, and at the post operative visit which occurred within 21-days post-operatively.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, assessed at 1h, 2h, 4h, 6h, 12h and 24h post operatively, then every 24 hours until discharge, and at the post operative visit which occurred within 21-days post-operatively.

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, assessed at 1h, 2h, 4h, 6h, 12h and 24h post operatively, then every 24 hours until discharge, and at the post operative visit which occurred within 21-days post-operatively. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Difference in Post-operative Pain Scores Measured by Visual Analog Scale

Secondary outcome measures

Duration of Post-operative Ileus

First Ambulation in the Hallway

Length of Hospital Stay

+4 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Treatment groupActive Control1 Intervention

Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution

Group II: Control groupPlacebo Group1 Intervention

0.9% Sodium Chloride Injection

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor

362 Previous Clinical Trials

628,093 Total Patients Enrolled

Katie Murray, DOPrincipal Investigator - University of Missouri-Columbia

Ellis Fischel Cancer Center of University of Missouri, University of Missouri Hospital

2 Previous Clinical Trials

128 Total Patients Enrolled

Boris Mraovic, MDPrincipal InvestigatorUniversity of Missouri-Columbia

4 Previous Clinical Trials

141 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How perilous are the potential implications of Treatment group for participants?

"With Phase 4 trials being the final step before approval, Treatment group achieved a score of 3 throughout its safety assessment."

Answered by AI

What conditions typically warrant Treatment group as a prescribed drug?

"Treatment group is an effective means of mitigating increased intra ocular pressure (IOP) as well other issues such as nasal irritation, the excretion of toxic elements via the kidneys and sciatica."

Answered by AI

What additional investigations have been carried out with respect to the Treatment group?

"At present, 211 studies on Treatment group are ongoing. Of these trials, 53 have advanced to the third stage of research. Most of these experiments are based in Duarte, California; however 1461 other locations also host clinical trials for this medication."

Answered by AI

Are there any openings for participants in this research endeavor?

"Affirmative. According to the clinicaltrials.gov entry for this trial, it is presently recruiting participants and has done so since February 26th 2019 with a recent update on January 21st 2022. The study requires 40 patients at one location."

Answered by AI

What is the upper limit of participants for this clinical trial?

"Correct. Clinicaltrials.gov displays that this clinical trial is currently searching for eligible participants, which was initially posted on February 26th 2019 and recently amended on January 21st 2022. 40 patients are being recruited from 1 medical centre."

Answered by AI

Recent research and studies

Anesthesia & AnalgesiaJournal

Systemic Lidocaine to Improve Postoperative Quality of Recovery After Ambulatory Laparoscopic Surgery

De Oliveira, Gildasio S., Paul Fitzgerald, Lauren F. Streicher, R-Jay Marcus, and Robert J. McCarthy. 2012. “Systemic Lidocaine to Improve Postoperative Quality of Recovery After Ambulatory Laparoscopic Surgery”. Anesthesia & Analgesia. Ovid Technologies (Wolters Kluwer Health). doi:10.1213/ane.0b013e318257a380.

The Journal of PainJournal

Adverse Events Associated with Postoperative Opioid Analgesia: A Systematic Review

Wheeler, Michelle, Gary M. Oderda, Michael A. Ashburn, and Arthur G. Lipman. 2002. “Adverse Events Associated with Postoperative Opioid Analgesia: A Systematic Review”. The Journal of Pain. Elsevier BV. doi:10.1054/jpai.2002.123652.

Current UrologyJournal

Post-operative Pain Management in Patients Undergoing Robotic Urological Surgery

Batley, Sian E., Venkat Prasad, Nikhil Vasdev, and Gowrie Mohan-S. 2016. “Post-operative Pain Management in Patients Undergoing Robotic Urological Surgery”. Current Urology. Ovid Technologies (Wolters Kluwer Health). doi:10.1159/000442843.

Journal of EndourologyJournal